Preferreds Trading at the Largest Discounts

By Preferred Stock Channel Staff, updated Tue, January 21, 6:37 AM

This Slide: #1 of 25

#25. Fortress Biotech Inc | 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (NASDAQ:FBIOP) | -15.08% CURRENT DISCOUNT

Discount to Liquidation Preference: -15.08%	Average Discount in Category: -4.06%
Current Annualized Yield: 11.04%	Average Yield in Category: 10.44%
Days Since Last Ex-Div Date: 36 \| See Dividend History »	Categorization: Biotechnology

FBIOP — Key Stats

Series:	A
Redeemable?:	Yes
Call Date:	12/15/2022
Perpetual?:	Yes
Cumulative?:	Yes
Shares Offered:	1,000,000
Overallotment:	150,000
Liquidation Preference:	$25
Recent Market Price:	$21.23
Discount to Liquidation Preference: (More Preferreds Trading at a Discount »)	$-3.77 (-15.08%)
Annualized Dividend:	2.34375
Recent Ex-Date:	12/12/2019
Current Yield:	11.04%
Original Coupon:	9.38%
Pay Period:	Quarterly
Pay Dates:	31-Mar, 30-Jun, 30-Sep, 31-Dec

About Fortress Biotech Inc (FBIO)

Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing pharmaceutical and biotechnology products. Co.'s product candidates include: MB-107 (XSCID), an ex vivo lentiviral gene therapy for the treatment of X-linked severe combined immunodeficiency; Intravenous Tramadol, for the treatment of moderate to moderately severe post-operative pain; and CUTX-101, a copper histidinate injection for the treatment of Menkes disease. Co.'s other product candidates include: ConVax, CEVA-101, CEVA-D and CEVA-102, TAMID-001, AVTS-001, CNDO-109 and Methazalomide.

Preferred: FBIOP

Open the FBIO Information Page »

FBIO — Key Stats (updated 20 HRs, 13 MINs ago)

Name:
Fortress Biotech Inc
Website:
www.fortressbiotech.com
Sector:
Biotechnology
Number of ETFs Holding FBIO:
4 (see which ones)
Total Market Value Held by ETFs:
$4,630,084
Total Market Capitalization:
$199,000,000
% of Market Cap. Held by ETFs:
2.33%